Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017
Sales, net	$ 12,001	$ 10,800	$ 22,305	$ 20,570
Cost of sales	10,671	9,752	19,756	18,517
Gross profit	1,330	1,048	2,549	2,053
Selling and administrative expenses	843	850	1,657	1,644
Operating income	487	198	892	409
Other income (expense), net
Interest expense	(190)	(229)	(390)	(462)
Change in fair value of derivative liabilities		185	9	67
Impairment on investment in iBio, Inc.		(168)		(251)
Other income, net	7	4	7	4
Other income (expense), net	(183)	(208)	(374)	(642)
Income (loss) before income taxes	304	(10)	518	(233)
Income tax expense, net	58	338	113	294
Net income (loss)	$ 246	$ (348)	$ 405	$ (527)
Basic net income (loss) per common share (in dollars per share)	$ 0.01	$ (0.02)	$ 0.01	$ (0.02)
Diluted net income (loss) per common share (in dollars per share)	$ 0.01	$ (0.02)	$ 0.01	$ (0.02)
Weighted average common shares outstanding - basic (in shares)	29,392,030	21,135,174	28,305,408	21,135,174
Add: Equivalent shares outstanding (in shares)	506,327		600,837
Shares issuable upon conversion of Convertible Debt - CD Financial, LLC (in shares)
Weighted average common shares outstanding - diluted (in shares)	29,898,357	21,135,174	28,906,245	21,135,174